In such cases, compounding pharmacies find themselves meeting the call for production as designated 503 entities are granted FDA clearance to compound and produce the product in question in an effort to help meet the national demand. One notable case has been the recent shortage of GLP-1 medications.
GLP-1s (Glucagon-like peptide-1) are medications classified as agonists that help lower blood sugar and, according to the American College of…
Read More…
Source: https://www.cleanroomtechnology.com/compounding-pharmacies-answering-the-call-for-production-in